Your institution may have rights to this item. Sign in to continue.
Title
P4-347: Tau aggregation inhibitor (TAI) therapy with rember<sup>™</sup> arrests the trajectory of rCBF decline in brain regions affected by Tau pathology in mild and moderate Alzheimer's disease (AD)